Johnny L Venter, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3125 Dr Russell Smith Way, Carthage, MO 64836 Phone: 417-358-8121 |
Anne E. Winkler, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3125 Dr Russell Smith Way, Carthage, MO 64836 Phone: 417-359-2675 Fax: 417-359-2679 |
Dr. Larry D Deffenbaugh, D.O. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3114 Medical Park Dr, Carthage, MO 64836 Phone: 620-783-2430 |
News Archive
Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.
The road to type 2 diabetes is paved with insulin resistance, a condition often associated with obesity in which the hormone begins to fail at its job helping to convert sugars to energy.
AyoxxA Biosystems, an international biotechnology company, today announces it has closed a 2.6 million Euro Series A financing round. The round was led by Wellington Partners Venture Capital and included NRW.BANK, HTGF - High-Tech-Gründerfonds, and private investors, Rainer Christine and Dr. Gregor Siebenkotten, both formerly executive board members and co-founders of amaxa biosystems.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today presented additional interim data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement. The data were presented at the Chemotherapy Foundation Symposium being held in New York City.
› Verified 2 days ago